Source: Annual Congress 2007 - Clinical outcome studies and technical aspects of paediatric lung function testing
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Barker, G. Brasse, L. Hülsmeier, D. Klemp (Aachen, Jülich, Germany). Diagnostic potential of organic halides as breath biomarkers in cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 1430

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compound breath signatures of children with cystic fibrosis by real-time SESI-HRMS Source: ERJ Open Res, 6 (1) 00171-2019; 10.1183/23120541.00171-2019 Year: 2020 Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis Source: Eur Respir J 2006; 27: 929-936 Year: 2006 Detection of elevated 2-propanol in breath samples from children with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 309s Year: 2006 Exhaled pentane – a new breath test in cystic fibrosis? Source: Annual Congress 2006 - New developments in infant and intensive care lung function Year: 2006 Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway Source: Eur Respir J 2010; 35: 781-786 Year: 2010 Diagnostic efficiency of sweat conductivity testing in cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Ionic composition of exhaled breath condenesate in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 8s Year: 2001 Nitrogen multiple breath washout indices as potentially prognostic markers in idiopathic pulmonary fibrosis Source: International Congress 2017 – Lung function testing Year: 2017 Volatile organic compounds may provide a new and promising tool for diagnosing interstitial lung diseases Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Correlation between inflammatory and oxidation markers in adults with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008 Nitrogen multiple breath washout test for infants with cystic fibrosis Source: Eur Respir J, 52 (2) 1800015; 10.1183/13993003.00015-2018 Year: 2018 Exhaled volatile organic compounds in idiopathic pulmonary fibrosis and disease progression Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 Volatile organic compounds in COPD: Is hexanal an inflammation biomarker? Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 Is NO2/X index useful for evaluation of oxidative stress in exhaled breath condensate in cystic fibrosis? Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Volatile organic compounds increase the likelihood of detecting malignant pleural mesothelioma Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Comparison of EBC biomarkers in cystic fibrosis and bacterial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis Source: Eur Respir J 2003 Dec 01;22(6):972-979 Year: 2003 Assessment of alveolar-capillar membrane of respiratory tract in patients with cystic fibrosis using single breath diffusion Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005